share_log

D. Boral Capital Initiates Coverage On MediciNova With Buy Rating, Announces Price Target of $9

D. Boral Capital Initiates Coverage On MediciNova With Buy Rating, Announces Price Target of $9

D. Boral Capital对美第奇新星生物技术启动覆盖,给予买入评级,并宣布价格目标为9美元。
Benzinga ·  12/02 08:30  · 评级/大行评级

D. Boral Capital analyst Jason Kolbert initiates coverage on MediciNova (NASDAQ:MNOV) with a Buy rating and announces Price Target of $9.

D. Boral Capital 分析师 Jason Kolbert 对美第奇新星生物技术(纳斯达克:MNOV)进行覆盖,给予买入评级,并宣布价格目标为9美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发